Consejo Nacional de Salud

398
106 De Conti P, Atallah ÁN, Arruda HO, Soares B, El
Dib R, Wilt T. Intermittent versus continuous androgen
suppression for prostatic cancer. Cochrane
Database of Systematic Reviews 2007, Issue 4.
Art. No.: CD005009. DOI: 10.1002/14651858.
CD005009.pub2.
107 Gibson LJ, Dawson CL, Lawrence DJ, Bliss JM. Aromatase
inhibitors for treatment of advanced breast
cancer in postmenopausal women. Cochrane
Database of Systematic Reviews 2007, Issue 1.
Art. No.: CD003370. DOI: 10.1002/14651858.
CD003370.pub2.
108 Gibson LJ, Dawson CL, Lawrence DJ, Bliss JM. Aromatase
inhibitors for treatment of advanced breast
cancer in postmenopausal women. Cochrane
Database of Systematic Reviews 2007, Issue 1.
Art. No.: CD003370. DOI: 10.1002/14651858.
CD003370.pub2.
109 Cheng AC, Stephens DP, Currie BJ. Granulocyte-
Colony Stimulating Factor (G-CSF) as an adjunct
to antibiotics in the treatment of pneumonia in
adults. Cochrane Database of Systematic Reviews
2007, Issue 2. Art. No.: CD004400. DOI:
10.1002/14651858.CD004400.pub3
110 Casetta I, Iuliano G, Filippini G. Azathioprine for
multiple sclerosis. Cochrane Database of Systematic
Reviews 2007, Issue 4. Art. No.: CD003982.
DOI: 10.1002/14651858.CD003982.pub2
111 Clerico M, Faggiano F, Palace J, Rice G, Tintorè
M, Durelli L. Recombinant interferon beta or glatiramer
acetate for delaying conversion of the first
demyelinating event to multiple sclerosis. Cochrane
Database of Systematic Reviews 2008, Issue 2.
Art. No.: CD005278. DOI: 10.1002/14651858.
CD005278.pub3.
112 Myers RP, Regimbeau C, Thevenot T, Leroy V,
Mathurin P, Opolon P, Zarski JP, Poynard T. Interferon
for acute hepatitis C. Cochrane Database
of Systematic Reviews 2001, Issue 4. Art. No.:
CD000369. DOI: 10.1002/14651858.CD000369.
113 Myers RP, Regimbeau C, Thevenot T, Leroy V,
Mathurin P, Opolon P, Zarski JP, Poynard T. Interferon
for interferon naive patients with chronic
hepatitis C. Cochrane Database of Systematic Reviews
2002, Issue 2. Art. No.: CD000370. DOI:
10.1002/14651858.CD000370
114 Myers RP, Poynard T. Interferon for interferon
nonresponding and relapsing patients with chronic
hepatitis C. Cochrane Database of Systematic
Reviews 2002, Issue 4. Art. No.: CD003617. DOI:
10.1002/14651858.CD003617
115 Mellerup MT, Krogsgaard K, Mathurin P, Gluud
C, Poynard T. Sequential combination of glucocorticosteroids
and alfa interferon versus alfa
interferon alone for HBeAg-positive chronic
hepatitis B. Cochrane Database of Systematic
Reviews 2005, Issue 3. Art. No.: CD000345. DOI:
10.1002/14651858.CD000345.pub2.
116 Simin M, Myers RP, Stimac D, Gluud C. Pegylated
interferon for acute hepatitis C. (Protocol)
Cochrane Database of Systematic Reviews
2007, Issue 1. Art. No.: CD006392. DOI:
10.1002/14651858.CD006392
117 Myers RP, Regimbeau C, Thevenot T, Leroy V,
Mathurin P, Opolon P, Zarski JP, Poynard T. Interferon
for acute hepatitis C. Cochrane Database
of Systematic Reviews 2001, Issue 4. Art. No.:
CD000369. DOI: 10.1002/14651858.CD000369
118 Webster AC, Playford EG, Higgins G, Chapman
JR, Craig J Interleukin 2 receptor antagonists (IL2-
Ra) reduce the risk of acute rejection episodes at
six and twelve months after kidney transplantation,
The Cochrane Database of Systematic Reviews
2006 Issue 4, 2006 The Cochrane Collaboration.
119 Goodman & Gilman, Las bases farmacológicas de
la Terapéutica, 1374, 1422,, 11ma ed, Mc Graw
Hill, 2006